RAPP
Rapport Therapeutics, Inc.
39.70$
-2.0%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| – | – | – | – | |
| – | +584.4% | +649.1% | +21.2% | |
| – | +478.0% | +190.4% | +84.2% | |
| – | +78.2% | -191.1% | – | |
| – | +476.1% | +47.0% | -74.4% | |
| – | +1,392.4% | +115.8% | +10.2% | |
| – | – | -100.0% | – | |
| – | – | – | – | |
| – | +265.7% | +52.7% | +22.2% | |
| – | +25.5% | -134.1% | – | |
| – | – | – | – |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.